Amarin shares fall on FDA review of Vascepa combination therapy
(Reuters) - Shares of Amarin Corporation Plc fell 20 percent on Friday on concerns the U.S. Food and Drug Administration will reject its application t...
Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/MmkzFQZldio/story01.htm
No comments:
Post a Comment